AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

AbCellera to Report Second Quarter 2021 Financial Results on August 12, 2021

July 22, 2021 GMT

VANCOUVER, British Columbia--(BUSINESS WIRE)--Jul 22, 2021--

AbCellera (Nasdaq: ABCL) will announce its second quarter 2021 financial results on Thursday, August 12, 2021 and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

The live webcast of the earnings conference call will be available through a link that will be posted on AbCellera’s Investor Relations website. A replay of the webcast will be available through the same link following the conference call.

About AbCellera Biologics Inc.

ADVERTISEMENT

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. For more info, visit www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210722005812/en/

CONTACT: Inquiries

Media: Jessica Yingling, Ph.D.;media@abcellera.com, +1(236)521-6774

Investor Relations: Melanie Solomon;ir@abcellera.com, +1(778)729-9116

KEYWORD: NORTH AMERICA CANADA

INDUSTRY KEYWORD: HEALTH OTHER SCIENCE GENERAL HEALTH RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: AbCellera Biologics Inc.

Copyright Business Wire 2021.

PUB: 07/22/2021 04:05 PM/DISC: 07/22/2021 04:06 PM

http://www.businesswire.com/news/home/20210722005812/en